VendorInvestigate result on a Shanghai mazdutide lot lands 2.8 points below the supplier’s figure
The supplier has not disputed the finding. It has not explained the gap either.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Sterility
Particulate matter is the oldest quality attribute in injectable manufacture and the one a private buyer is best placed to assess without instrumentation.
Sterility is a property of a system, not of a solution, and the system includes the glass, the elastomeric closure, the aluminium overseal and the interference fit between them. A batch filled under impeccable conditions into vials whose stoppers do not seat correctly is not a sterile batch after the first week of transport. This is well understood in regulated manufacture, where container closure integrity is a validated attribute tested at defined intervals across shelf life, and almost entirely absent from the documentation available in the research-peptide trade.
An aseptic process simulation, generally called a media fill, replaces the product with a sterile growth medium and runs the line exactly as it would run for a real batch: same components, same interventions, same operators, same duration. Every filled unit is then incubated and examined for growth. The purpose is to estimate the contamination rate of the process itself.
The arithmetic constrains the design. To support a claim that the contamination rate is below one unit in a thousand with reasonable statistical confidence, several thousand units must be filled with no contaminated unit recovered. Contemporary practice runs simulations of five to ten thousand units and treats a single positive as a signal requiring investigation rather than as an acceptable rate. The simulations are repeated at defined intervals and after any significant change to the line, and they are the closest thing in manufacturing to a direct measurement of aseptic capability.
One company in the Journal’s correspondence provided media fill records. They covered three simulations across eighteen months, at scales between four and six thousand units, with no recovered contamination. We report that because it is the only such record we have seen from this trade, and because it demonstrates that the documentation exists and can be shared when a company chooses to.
The compendial guidance divides leak test methods into probabilistic and deterministic families and is explicit about preferring the second. Probabilistic methods — dye ingress under vacuum, microbial immersion challenge, bubble emission — rely on a sequence of stochastic events, and their sensitivity is poor and hard to quantify. A dye ingress test can pass a container with a defect large enough to admit an organism, because the dye happened not to travel.
Deterministic methods measure a physical quantity with a continuous response. Vacuum decay monitors pressure rise in an evacuated test chamber. High-voltage leak detection measures current through the container wall and is well suited to liquid-filled units. Laser-based headspace analysis interrogates the gas inside a sealed container non-destructively, which permits repeated measurement of the same unit across a stability programme. Helium mass spectrometry resolves the smallest defects of any method in routine use.
The threshold that matters is the maximum allowable leakage limit — the defect size below which microbial ingress does not occur under the conditions the product will see. Establishing it for a given package is a piece of work, and once established it converts an argument about seals into a measurement.1
The four services have raised the documentation floor of this trade. That is exactly why it matters what their reports do not cover.
Nikolaj Brandvold, Contributing Writer, SterilityA multiple-dose closure is engineered to reseal after a defined number of penetrations by a needle of defined gauge, and the qualification data behind that claim is generated with a specific needle geometry at a specific rate. Beyond that number, the resealing behaviour is not characterised, and the failure is not usually dramatic: the elastomer simply stops closing fully behind the needle track.
Two related phenomena deserve naming. Coring is the removal of a fragment of elastomer by the needle tip, which both leaves a particle in the solution and creates a channel that does not reseal. It is more likely with larger-gauge needles, with repeated penetration through the same point, and with a needle that has already been used and blunted. Fragmentation testing is a compendial requirement for elastomeric closures precisely because of it.
The practical inference available to a reader is not a recommendation, because this publication does not make those. It is an observation about the object: a closure has a puncture budget, that budget is a number somebody determined experimentally, nobody in this trade publishes it, and the elastomer behaves according to the number rather than according to what anybody assumed. Rotating the entry point and using a fresh needle each time are answers to a mechanical problem, not to a microbiological one.
| Determination | Method family | Sample | Turnaround | Relative cost |
|---|---|---|---|---|
| Purity | Reversed-phase HPLC, UV | A few mg, non-destructive to batch | 2–7 days | 1× |
| Identity | LC–MS, optionally MS/MS | A few mg | 3–10 days | 1–2× |
| Peptide content | Elemental N or quantitative AAA | Several mg | 2–4 weeks | 2.5–3× |
| Bacterial endotoxin | Kinetic chromogenic LAL or rFC | <1 mL reconstituted | 3–10 days | 2–3× |
| Sterility | Membrane filtration, 14-day incubation | Entire container, destroyed | 3–4 weeks | 6–10× |
| Relative cost is expressed against a single generic-gradient purity run as 1×, from quotations obtained by the Journal from contract laboratories during the year. Sterility pricing assumes a single container rather than a compendial sample of twenty. | ||||
Injectable products are required to be essentially free of visible particulates, and every container in a regulated batch is inspected against dark and light backgrounds under defined illumination. The detection threshold for a trained inspector is somewhere near fifty microns for a contrasting particle, and the inspection is a hundred per cent operation rather than a sample-based one, which makes it unusual among quality tests.
Subvisible particles are counted instrumentally. Light obscuration is the primary compendial method, with microscopic membrane counting as the alternative when the sample defeats it. For a small-volume injection the limits are six thousand particles at or above ten microns and six hundred at or above twenty-five microns per container. Products that are themselves proteinaceous get a distinct chapter, because inherent aggregates complicate the counting and the method has to distinguish them from extrinsic contamination.
For a private buyer, visible inspection is the one quality operation available without instrumentation, and it is worth doing carefully: a lyophilised cake that has collapsed to a glassy disc, a reconstituted solution showing a faint tyndall haze on rotation, a fibre against a dark card. None of those is a sterility finding. All of them are evidence about how the product was made and how it has travelled.23
A lyophilised plug is a physical record of the cycle that produced it. A well-formed cake occupies close to the volume of the solution that was frozen, has a matte, uniform appearance, retains a defined edge where it met the glass, and dissolves rapidly and completely on addition of diluent. That appearance indicates that the product was frozen below its critical formulation temperature and dried without the structure collapsing.
Departures are informative. A shrunken, translucent or glassy plug suggests collapse during primary drying — the ice sublimed faster than the amorphous matrix could hold its structure — which is associated with higher residual moisture and a shorter shelf life. A cake that has partly detached and moves freely suggests mechanical handling after drying, which is cosmetic. A cake showing melt-back at the base, or a visible meniscus line, suggests a shelf temperature excursion. Slow or incomplete reconstitution suggests either collapse or an unfavourable surface.
None of these observations is a purity finding, a sterility finding or an endotoxin finding, and it is important not to overclaim. What they are is the only direct evidence about process control that arrives in the box, and reading them costs nothing. The Journal photographs every cake it receives before opening the vial, for exactly that reason.4
The compendial material in this article is drawn from the current general chapters of the United States Pharmacopeia and the European Pharmacopoeia, read in the original rather than in summary, and from the international standards on aseptic processing and on laboratory competence. Where a chapter has changed status recently — as the recombinant reagent chapters have — we say so, because a reader consulting an older edition will find a different framing.
Where the Journal reports a number it obtained itself, it states the laboratory’s accreditation status, the method family, whether method suitability was established, and the number of determinations. Where we report what a company told us, we distinguish an answer from a refusal and a refusal from a non-response, because those three things are routinely collapsed in coverage of this trade and they are not the same.
Corrections to this department are handled by the standards desk, which reads every letter and records the outcome in the log. Readers who believe a paragraph here overstates its evidence are asked to write to standards@compoundjournal.com; readers with documents to send, including certificates they would like read, should write to letters@compoundjournal.com. We do not publish correspondents’ names without permission and we do not identify the source of a certificate.
The sterility half is not solvable within the current economics, and it would be dishonest to pretend otherwise. Fourteen days, two media, a destroyed container and a statistical yield that passes most contaminated batches: no commercial testing service can build a product out of that for private buyers, and none has tried. The honest position is that this attribute is not verifiable downstream and must be assured upstream or not at all.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
You write that recombinant factor C is insensitive to the glucan branch of the cascade. It would be worth adding why anybody cares: cellulose filter media and certain paper wrappings shed glucans, and a laboratory that has chased a false positive through three repeat assays will never willingly go back to a reagent that responds to them.
— P. Hollingsworth, Norwich
Your endotoxin table gives vial 12 at 112 EU per vial and then declines to say whether that is dangerous. I understand why. It is still frustrating to read a figure of that size next to the sentence "arithmetic, not a safety assessment".
— F. Okonjo, Asaba
We understand the frustration and we are going to keep doing it. The figure sits at roughly a third of the hourly systemic allowance for a 70 kg adult if the whole vial were administered at once, which is a comparison a reader can make. What we cannot do is turn a single determination on one vial into a statement about a person, and pretending otherwise would be the more serious failure.
The supplier has not disputed the finding. It has not explained the gap either.
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Calibration drift is real, unremarkable, and the reason serious laboratories run internal standards.
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
Aseptic technique here is four steps and none of them are difficult. They are, however, routinely compressed to two.
A substudy powered to describe a mean is not a substudy powered to detect a clinically meaningful individual change.